1. Health Canada advises that Male Power Plus contains tadalafil

   Media release 21 January 2013 Pages: 2 - 2

2. Isotretinoin risk management to be strengthened in the US

   Media release 21 January 2013 Pages: 2 - 2

3. Rosuvastatin: more reports of rhabdomyolysis in Canada

   News item 21 January 2013 Pages: 2 - 2

4. Angiotensin receptor antagonists may increase MI risk

   Review 21 January 2013 Pages: 3 - 3

5. Changes to isotretinoin risk management needed

   Review 21 January 2013 Pages: 3 - 3

6. US FDA addresses postmarketing drug surveillance concerns

   News item 21 January 2013 Pages: 3 - 3

7. Duloxetine-induced nausea mild to moderate

   Incidence study 21 January 2013 Pages: 4 - 4

8. Flu vaccine-related Guillain-Barre syndrome reports decreasing

   Incidence study 21 January 2013 Pages: 4 - 4

9. Rofecoxib actions at molecular level explain CV effects?

   Media release 21 January 2013 Pages: 4 - 4

10. US guidelines for aspirin use applicable to other populations?

    News item 21 January 2013 Pages: 4 - 4

11. Antidepressants do not increase suicide attempts by adolescents

    Clinical study 21 January 2013 Pages: 5 - 5

12. Antiepileptic drugs associated with increased fracture risk

    Incidence study 21 January 2013 Pages: 5 - 5

13. Isotretinoin no adverse effect on adolescent BMD

    Clinical study 21 January 2013 Pages: 5 - 5

14. Rosiglitazone increases HF risk in insulin-treated type 2 diabetes patients

    Clinical study 21 January 2013 Pages: 5 - 5

15. Sildenafil + red wine: no adverse haemodynamic interaction

    Volunteers 21 January 2013 Pages: 5 - 5

16. Amoxicillin

    Case report 21 January 2013 Pages: 6 - 6

17. Anagrelide

    Case report 21 January 2013 Pages: 6 - 6

18. Analgesics

    Case report 21 January 2013 Pages: 6 - 6

19. Azithromycin

    Case report 21 January 2013 Pages: 7 - 7

20. Cefuroxime axetil

    Case report 21 January 2013 Pages: 7 - 7

21. Celecoxib

    Case report 21 January 2013 Pages: 7 - 7

22. Clobetasol

    Case report 21 January 2013 Pages: 7 - 7

23. Cyamemazine/venlafaxine

    Case report 21 January 2013 Pages: 8 - 8

24. Dorzolamide

    Case report 21 January 2013 Pages: 8 - 8

25. Gefitinib

    Case report 21 January 2013 Pages: 8 - 8

26. Hydrochlorothiazide/lisinopril

    Case report 21 January 2013 Pages: 8 - 9

27. Immunoglobulins

    Case report 21 January 2013 Pages: 9 - 9

28. Infliximab

    Case report 21 January 2013 Pages: 9 - 9

29. Infliximab

    Case report 21 January 2013 Pages: 9 - 9

30. Infliximab

    Case reports 21 January 2013 Pages: 10 - 10

31. Interferon-α/interferon-α-2b

    Case reports 21 January 2013 Pages: 10 - 10

32. Interferon-β-1a

    Case report 21 January 2013 Pages: 10 - 11

33. Interleukin 2

    Case reports 21 January 2013 Pages: 11 - 11

34. Lidocaine

    Case report 21 January 2013 Pages: 11 - 11

35. Lidocaine overdose

    Case report 21 January 2013 Pages: 11 - 11

36. Linezolid

    Case report 21 January 2013 Pages: 11 - 12

37. Lofexidine

    Case report 21 January 2013 Pages: 12 - 12

38. Methylthioninium chloride

    Case report 21 January 2013 Pages: 12 - 12

39. Nafcillin

    Case report 21 January 2013 Pages: 12 - 13

40. Paroxetine

    Case report 21 January 2013 Pages: 13 - 13

41. Phenobarbital

    Case report 21 January 2013 Pages: 13 - 13

42. Rituximab

    Case report 21 January 2013 Pages: 13 - 13

43. Ropivacaine

    Case report 21 January 2013 Pages: 14 - 14

44. Smallpox vaccine

    Case report 21 January 2013 Pages: 14 - 14

45. Tamoxifen

    Case report 21 January 2013 Pages: 14 - 14

46. Tegafur/uracil

    Case report 21 January 2013 Pages: 14 - 14

47. Ticlopidine

    Case report 21 January 2013 Pages: 14 - 15